MedPath

Application of Electronic Endoscope in Fetal Distress

Not Applicable
Not yet recruiting
Conditions
Fetal Distress
Fetal Hypoxia
Interventions
Device: endoscope application
Registration Number
NCT06608654
Lead Sponsor
The First Affiliated Hospital with Nanjing Medical University
Brief Summary

Fetal distress is a common emergency in obstetrics, which refers to the combined symptoms of fetal health and life in utero due to acute or chronic hypoxia, with an incidence of 2.7% to 38.5%. Fetal distress is mainly related to abnormal amniotic fluid, umbilical cord entanglement and compression, which is an important reason for the increase of cesarean section rate during delivery. At present, the diagnosis of fetal distress mainly relies on electronic monitoring of fetal heart, and the false positive rate is high. Intrauterine pressure catheter has not been widely used because of the little effect of intrauterine treatment and the increase of infection. Endoscopy has been widely used in the diagnosis and treatment of various specialties at present, but the diagnosis and treatment during childbirth are still in a blind area. The characteristics of endoscopic visualization provide a new idea for the diagnosis and treatment of fetal distress during delivery, especially for the etiological diagnosis and treatment of umbilical cord factors. The use of intraauterine endoscope during delivery can make up for the defects of intrauterine pressure catheter, realize the visual diagnosis of the causes of fetal distress such as oligoamniotic fluid, meconium contamination of amniotic fluid, umbilical cord compression caused by entangling and true junction, etc. At the same time, it can also improve the intrauterine environment by perfusion of saline for the causes of fetal embarrassment, correct fetal distress, and extend the observation time during labor. It is beneficial to reduce caesarean section during labor.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
Female
Target Recruitment
15
Inclusion Criteria
  1. Subjects aged 20-45 years with single pregnancy;
  2. Intrauterine fetal distress occurs during labor (during the first stage of labor), and the fetal membrane was already broken;
  3. Fetal heart monitoring category II, after stopping oxytocin, oxygen inhalation, change of position, intravenous fluid and other measures can not improve;
  4. Understand the research procedures, be able to follow the procedures of the research protocol, and voluntarily sign a written consent.
Exclusion Criteria
  1. Type III fetal heart monitoring for pregnant women who require emergency c-section
  2. Pregnant women with GBS positive
  3. Pregnant women suspected of chorioamniotic infection
  4. Pregnant women have signs of reproductive system infection (vaginal inflammation, cervicitis, uterine infection)
  5. Pregnant women suspected of uterine rupture
  6. Pregnant women with abnormal contractions: excessive strong contractions
  7. Check the fetus for serious deformities during pregnancy
  8. Check pregnant women with serious abnormal functions of cardiovascular system, urinary system, digestive system, reproductive system and other organs

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
fetal distressendoscope application-
Primary Outcome Measures
NameTimeMethod
fetal distress ratethrough study completion, an average of 1 year

fetal distress rate during first stage of labor

Secondary Outcome Measures
NameTimeMethod
vaginal delivery ratethrough study completion, an average of 1 year

baby was deliverd vaginally

Incidence of maternal infectionthrough study completion, an average of 1 year

materna infection was diagnozed up to 42 days after delivery

Neonatal asphyxia ratethrough study completion, an average of 1 year

Neonatal asphyxia was diagnozed after the baby was deliverd

neonatal NICU admission ratethrough study completion, an average of 1 year

Trial Locations

Locations (1)

First Affiliated Hospital of Nanjing Medical University

🇨🇳

Nanjing, Jiangsu, China

© Copyright 2025. All Rights Reserved by MedPath